Search

Astellas Pharma Inc.
  • Top MenuAbout
    • Philosophy
    • Vision
    • About Astellas MEA
      • Astellas South Africa
        • Event Privacy Notice
        • Business Partner Privacy Notice
        • Healthcare Professionals (HCP) Privacy Notice
    • Our commitment
    • Support for Medical Education
  • Top MenuSustainability
  • Top MenuCareers
  • Top MenuNEWS

Common header menu

  • CONTACT US
  • WORLDWIDE
  • MEA
  • WORLDWIDE - MEA
  1. Home
  2. News
  3. News

News

  • Latest
  • Keyword
  • Date
Search
  • 2025
  • 2024
  • 2023
  • Latest
    • 2022
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
Error

Feb, 2023

Global
News / Stories
Feb 23, 2023
Astellas Pharma introduces first of its kind treatment for anaemia associated with chronic kidney disease in Egypt
  • Chronic kidney disease (CKD) is the fifth leading cause of death in Egypt; burden of CKD increased by 36% from 2009 – 2019.2
  • Anaemia, a common complication of CKD, is associated...
Read More

Nov, 2022

Global
News / Stories
Nov 06, 2022
Astellas inaugurates Cairo-based Scientific Office

The global pharmaceutical company intends to accelerate future launches for medication that address unmet medical needs in the country.

egypt_office_ribbon_cutting

The ribbon cutting ceremony, held on 6...

Read More

Jun, 2022

Global
News / Stories
Jun 06, 2022
Astellas inaugurates Riyadh-based Scientific and Technical Regional Office

Astellas intends to accelerate future launches and new indications for medications,increase commitment in technology and local knowledge transfer and create new job opportunities for...

Read More
Nothing Found

Unfortunately, we weren't able to find a match for you.

Nothing Found

Unfortunately, we weren't able to find a match for you.

 

Back to Newsroom
LogoSolgan

Bottom footer menu

  • SITE MAP
  • PROCUREMENT
  • PRIVACY NOTICE
  • TERMS AND CONDITIONS
  • COOKIES POLICY
© Astellas Pharma DMCC

Update cookie preferences